Form 8-K - Current report:
SEC Accession No. 0001193125-22-079575
Filing Date
2022-03-18
Accepted
2022-03-18 16:49:59
Documents
12
Period of Report
2022-03-17
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d321053d8k.htm   iXBRL 8-K 37869
  Complete submission text file 0001193125-22-079575.txt   160489

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA arwr-20220317.xsd EX-101.SCH 2888
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE arwr-20220317_lab.xml EX-101.LAB 17996
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arwr-20220317_pre.xml EX-101.PRE 11283
6 EXTRACTED XBRL INSTANCE DOCUMENT d321053d8k_htm.xml XML 3361
Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-38042 | Film No.: 22753142
SIC: 2834 Pharmaceutical Preparations